Yamamoto et al., 2011), although there have been no human clinical trials
Never reuse needles or syringes, even for the same vial
Direct-to-Phase 2 or Fast Track: These applications allow the startup to either skip to Phase II directly or submit both Phase I and Phase II together in order to bridge the gap between the phases
They have more subsurface material waiting to be cleared
Many people looking for options besides surgery have started turning to these non-surgical fat reduction methods
Because of these limitations, any discussion of combined use should be understood as experimental, with key questions still unanswered regarding long-term safety, comparative effectiveness, pharmacokinetics, and systemic impact